Abstract:Abstract Background N 6 -methyladenosine (m 6 A) is the most abundant modification of RNA in eukaryotic cells and play critical roles in cancer. While most related studies focus on m 6 A modifications in linear RNA, transcriptome-wide profiling and exploration of m 6 A modification in circular RNAs in cancer is still lacking. Methods For the detection of m 6 A modification in circRNAs, we developed a new bioinformatics tools called Circm6A and applied it to the m 6 A-seq data of 77 tissue samples from 58 individuals with pancreatic ductal adenocarcinoma (PDAC). Results Circm6A performs better than the existing circRNA identification tools, which achieved highest F1 score among these tools in the detection of circRNAs with m 6 A modifications. By using Circm6A, we identified a total of 8807 m 6 A-circRNAs from our m 6 A-seq data. The m 6 A-circRNAs tend to be hypermethylated in PDAC tumor tissues compared with normal tissues. The hypermethylated m 6 A-circRNAs were associated with a significant gain of circRNA-mRNA coexpression network, leading to the dysregulation of many important cancer-related pathways. Moreover, we found the cues that hypermethylated m 6 A-circRNAs may promote the circularization and translation of circRNAs. Conclusions These comprehensive findings further bridged the knowledge gaps between m 6 A modification and circRNAs fields by depicting the m 6 A-circRNAs genomic landscape of PDAC patients and revealed the emerging roles played by m 6 A-circRNAs in pancreatic cancer. Circm6A is available at https://github.com/canceromics/circm6a .

Cross-talk between circRNAs and m6A modifications in solid tumors

Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer

Overview of m6A and circRNAs in human cancers

Interaction Between N6-methyladenosine Modification and the Tumor Microenvironment in Colorectal Cancer

The emerging roles of N6-methyladenosine RNA methylation in human cancers

Emerging roles of the crosstalk between non-coding RNAs and m<SUP>6</SUP>A modification in cancers

Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment

Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

The Roles of M6a RNA Modifiers in Human Cancer

The role of N6-methyladenosine (m6A) modification in the regulation of circRNAs

Novel insights into the interaction between N6-methyladenosine modification and circular RNA

The roles of m<SUP>6</SUP>A RNA modifiers in human cancer

The interaction between m6A modification and noncoding RNA in tumor microenvironment on cancer progression

The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma

N6-Methyladenosine Modification Opens a New Chapter in Circular RNA Biology

Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer

The interplay between m6A RNA methylation and noncoding RNA in cancer

Unraveling the cross‐talk between N6‐methyladenosine modification and non‐coding RNAs in breast cancer: Mechanisms and clinical implications

Genome-wide identification and characterization of circular RNA m6A modification in pancreatic cancer

The Roles of N6-methyladenosine and Its Target Regulatory Noncoding RNAs in Tumors: Classification, Mechanisms, and Potential Therapeutic Implications.